Log In
BCIQ
Print this Print this
 

BC8

  Manage Alerts
Collapse Summary General Information
Company Fred Hutchinson Cancer Research Center
DescriptionMAb against CD45
Molecular Target CD45
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsCancer
Regulatory Designation
PartnerActinium Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/16/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today